Previously treated cases tested for RR-/MDR-TB in Bosnia and Herzegovina
Bosnia and Herzegovina: Previously treated cases tested for RR-/MDR-TB was 89.0% in 2024. ▲ Rising
Previously treated cases tested for RR-/MDR-TB in Bosnia and Herzegovina, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for previously treated cases tested for rr-/mdr-tb in Bosnia and Herzegovina is 89.0%, measured in 2024.
The figure is up 9.9% on the previous year and up 61.8% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Bosnia and Herzegovina peaked at 100.0% in 2008 and was at its lowest, 47.0%, in 2010.
That places Bosnia and Herzegovina 87th out of 180 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 20 years of available data.
Previously treated cases tested for RR-/MDR-TB in Bosnia and Herzegovina, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 68.0% | — |
| 2006 | 82.0% | +20.6% |
| 2007 | 85.0% | +3.7% |
| 2008 | 100.0% | +17.6% |
| 2009 | 58.0% | -42.0% |
| 2010 | 47.0% | -19.0% |
| 2011 | 63.0% | +34.0% |
| 2012 | 55.0% | -12.7% |
| 2013 | 61.0% | +10.9% |
| 2014 | 55.0% | -9.8% |
| 2015 | 54.0% | -1.8% |
| 2016 | 67.0% | +24.1% |
| 2017 | 63.0% | -6.0% |
| 2018 | 71.0% | +12.7% |
| 2019 | 100.0% | +40.8% |
| 2020 | 85.0% | -15.0% |
| 2021 | 100.0% | +17.6% |
| 2022 | 100.0% | +0.0% |
| 2023 | 81.0% | -19.0% |
| 2024 | 89.0% | +9.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 78.6% | 58.0% | 100.0% | 5 |
| 2010s | 63.6% | 47.0% | 100.0% | 10 |
| 2020s | 91.0% | 81.0% | 100.0% | 5 |
Countries ranked near Bosnia and Herzegovina
- 87 Sudan 89.0% compare
- 87 Iran, Islamic Republic of 89.0% compare
- 90 Canada 88.0% compare
- 90 Equatorial Guinea 88.0% compare
More health data for Bosnia and Herzegovina
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.071 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,689 deaths per 1,000 people (2090)
- Number of infants who die before age 1 11 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.62 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.019 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.62 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Bosnia and Herzegovina?
- Previously treated cases tested for rr-/mdr-tb in Bosnia and Herzegovina was 89.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Bosnia and Herzegovina?
- The highest recorded value was 100.0% in 2008.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Bosnia and Herzegovina?
- The lowest recorded value was 47.0% in 2010.
- How does Bosnia and Herzegovina rank for previously treated cases tested for rr-/mdr-tb?
- Bosnia and Herzegovina ranks 87th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Bosnia and Herzegovina?
- Over the last ten years it is up 61.8%. The long-run trend across the full record is rising.
- Where does this Bosnia and Herzegovina data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).